Therapeutic Processes and Treatment Outcome in Adolescents With Anxiety Disorders - Tabular View

Tracking Information
First Received Date ^ICMJE	October 29, 2003
Last Updated Date	September 19, 2008
Start Date ^ICMJE	September 2002
Primary Completion Date
Current Primary Outcome Measures ^ICMJE
Original Primary Outcome Measures ^ICMJE
Change History	Complete list of historical versions of study NCT00071630 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE
Original Secondary Outcome Measures ^ICMJE

Descriptive Information
Brief Title ^ICMJE	Therapeutic Processes and Treatment Outcome in Adolescents With Anxiety Disorders
Official Title ^ICMJE	Process as a Predictor of Outcomes in CBT for Youth
Brief Summary	The purpose of this study is to examine the relationship between different aspects of cognitive behavior therapy (CBT) and treatment outcome.
Detailed Description	Anxiety disorders are common among children; if untreated, they can negatively affect children's lives. Evidence suggests that CBT can benefit children with anxiety disorders, but the causal mechanisms between therapy and beneficial outcomes have not been thoroughly investigated. Audio and videotaped sessions of children currently receiving CBT and those who received CBT in previous trials will be examined. Various rating scales will be used to rate therapeutic alliance, child involvement, and therapist flexibility for each session of CBT. To evaluate potential process variables that contribute to participant drop-out, this study will compare the early process variables for children who complete treatment and for those who discontinue treatment.
Study Phase	Phase IV
Study Type ^ICMJE	Interventional
Study Design ^ICMJE	Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Condition ^ICMJE	Anxiety Disorders
Intervention ^ICMJE	Behavioral: Cognitive Behavioral Therapy
Study Arms / Comparison Groups
Publications *
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE	130
Completion Date	August 2005
Primary Completion Date
Eligibility Criteria ^ICMJE	Inclusion criteria: Diagnosis of separation anxiety disorder, generalized anxiety disorder, or social phobia At least one English-speaking parent Exclusion criteria: IQ < 80 Psychotic symptoms
Gender	Both
Ages	8 Years to 13 Years
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	United States, Australia

Administrative Information
NCT ID ^ICMJE	NCT00071630
Responsible Party
Study ID Numbers ^ICMJE	R01 MH64484, DSIR CT-S
Study Sponsor ^ICMJE	National Institute of Mental Health (NIMH)
Collaborators ^ICMJE
Investigators ^ICMJE
Information Provided By	National Institute of Mental Health (NIMH)
Verification Date	September 2008
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP